100 related articles for article (PubMed ID: 1355008)
21. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
Wakusawa S; Nakamura S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
Mol Pharmacol; 1992 Jun; 41(6):1034-8. PubMed ID: 1614407
[TBL] [Abstract][Full Text] [Related]
22. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
23. Resistance to N-benzyladriamycin-14-valerate in mouse J774.2 cells: P-glycoprotein expression without reduced N-benzyladriamycin-14-valerate accumulation.
Lothstein L; Sweatman TW; Dockter ME; Israel M
Cancer Res; 1992 Jun; 52(12):3409-17. PubMed ID: 1350753
[TBL] [Abstract][Full Text] [Related]
24. New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors.
Zhou XF; Zhang L; Tseng E; Scott-Ramsay E; Schentag JJ; Coburn RA; Morris ME
Drug Metab Dispos; 2005 Mar; 33(3):321-8. PubMed ID: 15585608
[TBL] [Abstract][Full Text] [Related]
25. Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.
Smith CD; Zilfou JT; Stratmann K; Patterson GM; Moore RE
Mol Pharmacol; 1995 Feb; 47(2):241-7. PubMed ID: 7870031
[TBL] [Abstract][Full Text] [Related]
26. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
28. Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity.
Yoshinari T; Iwasawa Y; Miura K; Takahashi IS; Fukuroda T; Suzuki K; Okura A
Cancer Chemother Pharmacol; 1989; 24(6):367-70. PubMed ID: 2791190
[TBL] [Abstract][Full Text] [Related]
29. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
[TBL] [Abstract][Full Text] [Related]
30. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.
Zordan-Nudo T; Ling V; Liu Z; Georges E
Cancer Res; 1993 Dec; 53(24):5994-6000. PubMed ID: 7903200
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression.
McGrath T; Latoud C; Arnold ST; Safa AR; Felsted RL; Center MS
Biochem Pharmacol; 1989 Oct; 38(20):3611-9. PubMed ID: 2573357
[TBL] [Abstract][Full Text] [Related]
32. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
33. Effect of newly synthesized indole derivatives on multidrug resistance in human cancer cells.
Matsumoto T; Fujii R; Sugita M; Sumizawa T; Sakai S; Takahashi T; Sueda N; Furukawa T; Akiyama S; Nagata Y
Anticancer Drug Des; 1994 Jun; 9(3):251-61. PubMed ID: 7913322
[TBL] [Abstract][Full Text] [Related]
34. Activities of newly synthesized dihydropyridines in overcoming of vincristine resistance, calcium antagonism, and inhibition of photoaffinity labeling of P-glycoprotein in rodents.
Kiue A; Sano T; Suzuki K; Inada H; Okumura M; Kikuchi J; Sato S; Kohno K; Kuwano M
Cancer Res; 1990 Jan; 50(2):310-7. PubMed ID: 1967223
[TBL] [Abstract][Full Text] [Related]
35. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
[TBL] [Abstract][Full Text] [Related]
36. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
[TBL] [Abstract][Full Text] [Related]
37. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
[TBL] [Abstract][Full Text] [Related]
38. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
[TBL] [Abstract][Full Text] [Related]
39. Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.
Abraham I; Wolf CL; Sampson KE
Cancer Chemother Pharmacol; 1993; 32(2):116-22. PubMed ID: 8097968
[TBL] [Abstract][Full Text] [Related]
40. The multidrug transporter: rapid modulation of efflux activity monitored in single cells by the morphologic effects of vinblastine and daunomycin.
Konen PL; Currier SJ; Rutherford AV; Gottesman MM; Pastan I; Willingham MC
J Histochem Cytochem; 1989 Jul; 37(7):1141-5. PubMed ID: 2567301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
